ArticleACS omega2026
Harnessing Sequence Embedding and Ensemble Learning to Identify Antifungal Peptides with Low Hemolytic Risk.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing prevalence of fungal infections represents a growing threat to human health, driven in part by the misuse of antibiotics and the rising incidence of resistance to conventional antifungal agents. Antifungal peptides (AFPs) have emerged as promising alternatives due to their diverse mechanisms of action and their relatively low propensity to develop resistance. To facilitate the systematic discovery of AFPs, we developed AI4AFP. This computational framework integrates curated antifungal peptide resources with advanced machine learning approaches to predict antifungal potential directly from peptide sequences. Using a comprehensive data set, we constructed a seven-model ensemble that combines multiple sequence encoding strategies, including ProtBERT-BFD, PC6, and Doc2Vec, with diverse learning algorithms, including random forests, support vector machines, convolutional neural networks, and fine-tuned BERT models. This ensemble demonstrated robust performance on an independent test set, achieving 0.94 in accuracy and 0.89 in Matthews correlation coefficient, outperforming existing AFP prediction methods. Importantly, the predicted AFP score is intended to reflect the general antifungal potential rather than species-specific potency. Experimental validation against representative fungal pathogens, including
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.